TAK-861 Shows Promise in Phase 2b Narcolepsy Type 1 Trial
TAK-861 demonstrated significant and sustained improvements in the treatment of narcolepsy type 1 in a phase 2b clinical trial.
Source: sleepreviewmag.com
Page 2 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Therapy Today - Breaking & Trending Today
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for
MELBOURNE, Australia, June 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has...
Source: globenewswire.com
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings,...
Source: prnewswire.com
Novartis: positive trial results in chronic myeloid leukemia
Novartis presented positive results from the 'ASC4FIRST' trial at the ASCO 2024 meeting. The trial showed that Scemblix, a drug to treat chronic myeloid leukemia, achieved higher major molecular...
Source: marketscreener.com
Atacicept Gets Breakthrough Therapy Status for Immunoglobulin A Nephropathy
The designation is supported by data from the phase 2b ORIGIN trial.
Source: empr.com